Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook.
Almirall is expanding its business by buying Allergan’s dermatology portfolio. The Spanish pharma company will buy five brands from US-based Allergan for up to $650 million in cash.
Having been in development by Almirall and Eli Lilly and Company for moderate to severe AD, recent findings from a phase 3 trial for the first time have shown year-long (52-week) management of ...
Clásico 8.675 8.705 8.73 8.76 8.785 8.815 8.84 Fibonacci 8.705 8.726 8.739 8.76 8.781 8.794 8.815 Camarilla 8.74 8.745 8.75 8.76 8.76 8.765 8.77 Woodies 8.673 8.704 8.728 8.759 8.783 8.814 8.838 ...
Sareum will utilise its skills in high throughput protein expression, purification and structure determination to illustrate the precise nature of how Infinity’s potential drug candidates interact ...
Barcelona, 22 jul (.).- La farmacéutica catalana Almirall (BME:ALM) ganó 15,4 millones de euros en el primer semestre de este año, un 28,3 % más que en el mismo período anterior,... Mostrar más ...
09/10/2023 - 7:30 h.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback